255 related articles for article (PubMed ID: 34635114)
21. Clinical features and management of organic acidemias in Japan.
Fujisawa D; Nakamura K; Mitsubuchi H; Ohura T; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
J Hum Genet; 2013 Dec; 58(12):769-74. PubMed ID: 24067294
[TBL] [Abstract][Full Text] [Related]
22. Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
Armstrong AJ; Henke BR; Collado MS; Taylor JM; Pourtaheri TD; Dillberger JE; Roper TD; Wamhoff BR; Olson MW; Figler RA; Hoang SA; Reardon JE; Johns BA
J Med Chem; 2021 Apr; 64(8):5037-5048. PubMed ID: 33848153
[TBL] [Abstract][Full Text] [Related]
23. Evaluating renin and aldosterone levels in children with organic acidemia-therapeutic experience with fludrocortisone.
Tarçın G; Ahmadzada S; Saygılı S; Kaya A; Aktuğlu Zeybek AÇ; Ercan O
Eur J Pediatr; 2023 Dec; 182(12):5447-5453. PubMed ID: 37773296
[TBL] [Abstract][Full Text] [Related]
24. Rhabdomyolysis in organic acidemia patients manifesting with metabolic decompensation.
Kido J; Matsumoto S; Sawada T; Endo F; Nakamura K
Hemodial Int; 2019 Oct; 23(4):E115-E119. PubMed ID: 31476111
[TBL] [Abstract][Full Text] [Related]
25. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
Baumgartner MR; Hörster F; Dionisi-Vici C; Haliloglu G; Karall D; Chapman KA; Huemer M; Hochuli M; Assoun M; Ballhausen D; Burlina A; Fowler B; Grünert SC; Grünewald S; Honzik T; Merinero B; Pérez-Cerdá C; Scholl-Bürgi S; Skovby F; Wijburg F; MacDonald A; Martinelli D; Sass JO; Valayannopoulos V; Chakrapani A
Orphanet J Rare Dis; 2014 Sep; 9():130. PubMed ID: 25205257
[TBL] [Abstract][Full Text] [Related]
26. Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report.
Tummolo A; Melpignano L; Carella A; Di Mauro AM; Piccinno E; Vendemiale M; Ortolani F; Fedele S; Masciopinto M; Papadia F
J Med Case Rep; 2018 Apr; 12(1):103. PubMed ID: 29679984
[TBL] [Abstract][Full Text] [Related]
27. Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias.
Nizon M; Ottolenghi C; Valayannopoulos V; Arnoux JB; Barbier V; Habarou F; Desguerre I; Boddaert N; Bonnefont JP; Acquaviva C; Benoist JF; Rabier D; Touati G; de Lonlay P
Orphanet J Rare Dis; 2013 Sep; 8():148. PubMed ID: 24059531
[TBL] [Abstract][Full Text] [Related]
28. Organic acidemias in the neonatal period: 30 years of experience in a referral center for inborn errors of metabolism.
Unsal Y; Yurdakok M; Yigit S; Celik HT; Dursun A; Sivri HS; Tokatli A; Coskun T
J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1345-1356. PubMed ID: 36203204
[TBL] [Abstract][Full Text] [Related]
29. New insights into the pathophysiology of methylmalonic acidemia.
Head PE; Meier JL; Venditti CP
J Inherit Metab Dis; 2023 May; 46(3):436-449. PubMed ID: 37078237
[TBL] [Abstract][Full Text] [Related]
30. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
[TBL] [Abstract][Full Text] [Related]
31. Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.
Chu TH; Chien YH; Lin HY; Liao HC; Ho HJ; Lai CJ; Chiang CC; Lin NC; Yang CF; Hwu WL; Lee NC; Lin SP; Liu CS; Hu RH; Ho MC; Niu DM
Orphanet J Rare Dis; 2019 Apr; 14(1):73. PubMed ID: 30940196
[TBL] [Abstract][Full Text] [Related]
32. Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD).
Henriquez H; el Din A; Ozand PT; Subramanyam SB; al Gain SI
Brain Dev; 1994 Nov; 16 Suppl():86-93. PubMed ID: 7726386
[TBL] [Abstract][Full Text] [Related]
33. High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.
Molema F; Haijes HA; Janssen MC; Bosch AM; van Spronsen FJ; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Fuchs S; Langendonk JG; Rizopoulos D; van Hasselt PM; Williams M
Clin Nutr; 2021 May; 40(5):3622-3630. PubMed ID: 33451859
[TBL] [Abstract][Full Text] [Related]
34. NMR Spectroscopy in Diagnosis and Monitoring of Methylmalonic and Propionic Acidemias.
Deleanu C; Nicolescu A
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785935
[TBL] [Abstract][Full Text] [Related]
35. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report.
Jiang YZ; Shi Y; Shi Y; Gan LX; Kong YY; Zhu ZJ; Wang HB; Sun LY
Orphanet J Rare Dis; 2019 Dec; 14(1):292. PubMed ID: 31842933
[TBL] [Abstract][Full Text] [Related]
36. Multi-omics studies in cellular models of methylmalonic acidemia and propionic acidemia reveal dysregulation of serine metabolism.
Anzmann AF; Pinto S; Busa V; Carlson J; McRitchie S; Sumner S; Pandey A; Vernon HJ
Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165538. PubMed ID: 31449969
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.
Molema F; Jacobs EH; Onkenhout W; Schoonderwoerd GC; Langendonk JG; Williams M
J Inherit Metab Dis; 2018 Nov; 41(6):1179-1187. PubMed ID: 30159853
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders.
Monostori P; Klinke G; Richter S; Baráth Á; Fingerhut R; Baumgartner MR; Kölker S; Hoffmann GF; Gramer G; Okun JG
PLoS One; 2017; 12(9):e0184897. PubMed ID: 28915261
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential interferents of methylmalonic acid: A previously unrecognized pitfall in clinical diagnostics and newborn screening.
Monostori P; Godejohann M; Janda J; Galla Z; Rácz G; Klinke G; Szatmári I; Zsidegh P; Kohlmüller D; Kölker S; Hoffmann GF; Gramer G; Okun JG
Clin Biochem; 2023 Jan; 111():72-80. PubMed ID: 36202155
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies.
Haijes HA; van Hasselt PM; Jans JJM; Verhoeven-Duif NM
J Inherit Metab Dis; 2019 Sep; 42(5):745-761. PubMed ID: 31119742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
